AgeX Therapeutics, Inc. (AGE)

EPS Growth

-45.38%

TTM · Period ending:

AGE logo

AGE EPS Growth

Year-over-year change vs the same period a year earlier

Latest reported-45.38%
AGE TTM EPS YoY % (-53.98% → -45.38%)
High-resolution chart · PNG

AGE eps growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

AgeX Therapeutics, Inc. EPS Growth — Trailing twelve months (TTM)
Period endingEPS Growth
-45.3846%
-6,566.6667%
-26.4901%
56.5909%
86.4159%
99.7628%
90.4309%
70.8416%
27.2796%
10.0924%
-30.5211%
-30.3109%
-27.6431%
-52.603%
-50.1863%
-39.1827%
-16.2345%
-1.5419%
20.218%
19.5358%
19.1431%
19.9295%
11.5688%
13.8333%
1.2601%
-11.0676%
-53.9811%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.